A Russian article published in 2019 used the glucagon stimulation test in 28 patients that underwent craniospinal irradiation for neoplasms of the central nervous system without pituitary localization and in 10 healthy controls, performing both the glucagon and the insulin tolerance test to evaluate whether the HPA axis’ function was preserved or not. Here, GCG is linked to central nervous system neoplasm.